Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases
A clinical trial investigating skin autofluorescence as a noninvasive measure of advanced glycation end products across several rheumatic di…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts [Phase 1]
First-in-human Phase 1 study of SOL-116, a monoclonal antibody targeting BSSL, in rheumatoid arthritis has completed and posted results.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
Clinical trial update for the Shoulder iD primary reversed glenoid outcomes study; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Creating Health Course Study for People With Rheumatological Conditions [NA]
A new health course study for people with rheumatological conditions is currently recruiting, spanning rheumatoid arthritis, Sjögren's syndr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Duke University’s MADRA pregnancy autoimmune disease registry is actively recruiting to study autoimmune conditions during pregnancy, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis [NA]
A completed clinical trial update from Surf Therapeutics examining activation of the cholinergic anti-inflammatory pathway in healthy volunt…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
Pfizer-sponsored clinical trial update on a 100 mg infliximab biosimilar for rheumatoid arthritis. The study status is completed with result…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis [NA]
This clinical trial is examining how exercise training affects long noncoding RNA expression in individuals with rheumatoid arthritis. The s…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
The CAT-RA study is an observational research trial evaluating coronary artery calcium and troponin biomarkers in patients with rheumatoid a…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: The Effect of Cilostazol on Rheumatoid Arthritis Patients [Phase 2, Phase 3]
The trial update reports completion of Phase 2 and Phase 3 studies evaluating cilostazol in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: An Open-label Study of GC012F in Rheumatoid Arthritis. [EARLY_Phase 1]
An open-label Phase 1 study of GC012F for rheumatoid arthritis is ongoing, with the trial status listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Probiotics in Adults With Rheumatoid Arthritis [NA]
Ancilia Biosciences reports a clinical trial evaluating probiotic therapy in adults with rheumatoid arthritis that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
A clinical trial update indicates a study assessing the effects of phytocannabinoids on immune response and autophagy in chronic immune-medi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study [Phase 4]
A Phase 4 clinical trial (MONITORA) evaluating an individualized biodrug tapering strategy based on biodrug dosage for rheumatoid arthritis,…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. [Phase 2]
Phase 2 trial evaluating AlloNK, an allogeneic cord blood-derived NK cell therapy, in combination with Rituximab for relapsing B-cell–depend…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
A clinical trial in China is evaluating whether generative AI can improve the diagnosis of complications associated with rheumatoid arthriti…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
A completed real-world trial comparing TNF inhibitors, used as monotherapy or with methotrexate, to tofacitinib, used as monotherapy or with…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of a single intravenous infusion of BX-U001 in patients with refractory rheu…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Comprehensive Segmental Revision System
Clinical trial update for Zimmer Biomet's Comprehensive Segmental Revision System; the study is active but not recruiting, with indications …
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA) [Phase 4]
A Phase 4 trial (AFORA) evaluated whether serum adalimumab concentration can predict clinical outcomes in rheumatoid arthritis. The study ha…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: High-intensity Interval Exercise in Rheumatoid Arthritis [NA]
A clinical trial evaluating high-intensity interval exercise in rheumatoid arthritis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating vagus nerve stimulation for moderate to severe rheumatoid arthritis has posted results. The study is currently acti…
-
EMA approval · 2025-12-19EMA Authorised: Leflunomide medac (leflunomide) — medac Gesellschaft für klinische Spezialpräparate mbH
The EMA authorised Leflunomide medac (leflunomide) for treatment of rheumatoid arthritis. The marketing authorization holder is medac Gesell…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System
A multicenter observational study evaluating clinical outcomes of the Zimmer Biomet G7 Acetabular System in patients with osteoarthritis and…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: SBD121, a Synbiotic Medical Food for RA Management [NA]
The clinical trial of SBD121, a synbiotic medical food for rheumatoid arthritis management, has completed. Sponsor: Solarea Bio, Inc.